Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin.

The polyphenol mangiferin (MA) has been shown to have various effects on macrophage function, including inhibition of phagocytic activity and of free radical production. To further characterize the immunomodulatory activity of MA, this study investigated its effects on expression by activated mouse macrophages of diverse genes related to the NF-kappaB signaling pathway, using a DNA hybridization array containing 96 NF-kappaB-related genes and on cytokine levels using a cytokine protein array. MA at 10 microM significantly inhibited the expression of (a) two genes of the Rel/NF-kappaB/IkappaB family, RelA and RelB (=I-rel), indicating an inhibitory effect on NF-kappaB-mediated signal transduction; (b) TNF receptor-associated factor 6 (Traf6), indicating probable blockage of activation of the NF-kappaB pathway by lipopolysaccharide (LPS), tumor necrosis factor (TNF), and interleukin 1 (IL-1); (c) other proteins involved in responses to TNF and in apoptotic pathways triggered by DNA damage, including the TNF receptor (TNF-R), the TNF-receptor-associated death domain (TRADD), and the receptor interacting protein (RIP); (d) the extracellular ligand IL-1alpha, again indicating likely interference with responses to IL-1; (e) the pro-inflammatory cytokines IL-1, IL-6, IL-12, TNF-alpha and RANTES (CCL5), and cytokines produced by monocytes and macrophages, including granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF); (f) other toll-like receptor proteins (in addition to Traf6), including JNK1, JNK2 and Tab1; (g) Scya2 (small inducible cytokine A2=monocyte chemoattractant protein 1); and (h) various intracellular adhesion molecules (ICAMs), and the vascular cell adhesion molecule VCAM-1, which is locally increased in atheromas. The inhibition of JNK1, together with stimulation of c-JUN (i.e. the Jun oncogene) and the previously reported superoxide-scavenging activity of MA, suggests that MA may protect cells against oxidative damage and mutagenesis. Taken together, these results indicate that MA modulates the expression of a large number of genes that are critical for the regulation of apoptosis, viral replication, tumorogenesis, inflammation and various autoimmune diseases, and raise the possibility that it may be of value in the treatment of inflammatory diseases and/or cancer.

[1]  Li Wc.  Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases. , 2001 .

[2]  T. Gilmore,et al.  Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway , 1999, Oncogene.

[3]  M. Kohara,et al.  Induction of hepatic injury by hepatitis C virus-specific CD8+ murine cytotoxic T lymphocytes in transgenic mice expressing the viral structural genes. , 2003, Biochemical and biophysical research communications.

[4]  N. Ruddle.  Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development. , 1999, Immunologic research.

[5]  F. Ubeira,et al.  Respiratory burst responses of rat macrophages to microsporidian spores. , 2001, Experimental parasitology.

[6]  J. Naismith,et al.  TNFα and the TNF receptor superfamily: Structure‐function relationship(s) , 2000, Microscopy research and technique.

[7]  J. Chen,et al.  Intestinal inflammation observed in IL-2R/IL-2 mutant mice is associated with impaired intestinal T lymphopoiesis. , 2000, Gastroenterology.

[8]  A. Bowie,et al.  Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. , 2000, Biochemical pharmacology.

[9]  P. Scheurich,et al.  Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. , 2001, The international journal of biochemistry & cell biology.

[10]  J. Mizukami,et al.  TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways. , 2002, Biochemical and biophysical research communications.

[11]  H. Forman,et al.  Redox signaling in macrophages. , 2001, Molecular aspects of medicine.

[12]  A. Ding,et al.  Macrophages derived from C3H/HeJ (Lpsd ) mice respond to bacterial lipopolysaccharide by activating NF‐χB , 1995, Journal of leukocyte biology.

[13]  J. Leiro,et al.  Resveratrol modulates rat macrophage functions. , 2002, International immunopharmacology.

[14]  L. Neckers,et al.  Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. , 2003, The Biochemical journal.

[15]  M. Hansen,et al.  Identification of a Novel Tandem Duplication in Exon 1 of the TNFRSF11A Gene in Two Unrelated Patients With Familial Expansile Osteolysis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  R. Natarajan,et al.  Molecular Mechanisms of Tumor Necrosis Factor α Gene Expression in Monocytic Cells via Hyperglycemia-induced Oxidant Stress-dependent and -independent Pathways* , 2000, The Journal of Biological Chemistry.

[17]  E. Savilahti,et al.  Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease , 2002, Clinical and experimental immunology.

[18]  E. Prochownik,et al.  Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network , 1999, Oncogene.

[19]  G. Zhu,et al.  Substance P and Stress‐Induced Changes in Macrophages a , 1995, Annals of the New York Academy of Sciences.

[20]  I. Rahman.  Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. , 2002, Biochemical pharmacology.

[21]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[22]  A Garg,et al.  Nuclear transcription factor-κB as a target for cancer drug development , 2002, Leukemia.

[23]  F. Liu,et al.  Expression of a Novel, Sterol-Insensitive Form of Sterol Regulatory Element Binding Protein 2 (SREBP2) in Male Germ Cells Suggests Important Cell- and Stage-Specific Functions for SREBP Targets during Spermatogenesis , 2002, Molecular and Cellular Biology.

[24]  S. Akira.  Mammalian Toll-like receptors. , 2003, Current opinion in immunology.

[25]  A. J. Valente,et al.  Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. , 1988, Biochemistry.

[26]  M. Taskinen,et al.  Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. , 2003, Atherosclerosis.

[27]  Y. Surh,et al.  Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. , 2001, Mutation research.

[28]  P. Scheurich,et al.  The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. , 2001, Cellular signalling.

[29]  H. Fujiki,et al.  Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. , 2001, Biological & pharmaceutical bulletin.

[30]  Y. L. Lin,et al.  Theaflavin-3,3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages. , 1999, European journal of pharmacology.

[31]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[32]  T. Verbeuren,et al.  Effect of NADPH oxidase inhibition on E-selectin expression induced by concomitant anoxia/reoxygenation and TNF-alpha. , 2002, Endothelium : journal of endothelial cell research.

[33]  C. Strock,et al.  The Ras/Raf/MEK/Extracellular Signal-Regulated Kinase Pathway Induces Autocrine-Paracrine Growth Inhibition via the Leukemia Inhibitory Factor/JAK/STAT Pathway , 2003, Molecular and Cellular Biology.

[34]  M. Magnani,et al.  Modulation of ICAM-1 expression in ECV304 cells by macrophage-released cytokines. , 2001, Blood cells, molecules & diseases.

[35]  A. Farr,et al.  Oxidative Stress Induces NF-κB Nuclear Translocation Without Degradation of IκBα , 1999 .

[36]  N. Rose,et al.  Adhesion molecules as susceptibility factors in spontaneous autoimmune thyroiditis in the NOD-H2h4 mouse. , 2002, Experimental and molecular pathology.

[37]  S. Gygi,et al.  Correlation between Protein and mRNA Abundance in Yeast , 1999, Molecular and Cellular Biology.

[38]  J. Hawiger.  Innate immunity and inflammation: A transcriptional paradigm , 2001, Immunologic research.

[39]  N. Copeland,et al.  Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Jen-kun Lin,et al.  Suppression of lipopolysaccharide-induced nuclear factor-κB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IκB kinase activity in macrophages , 2000 .

[41]  R. Sapolsky,et al.  Novel glucocorticoid effects on acute inflammation in the CNS , 2003, Journal of neurochemistry.

[42]  E. Lien,et al.  Toll-like receptors. , 2002, Critical care medicine.

[43]  G. Piraino,et al.  Mitogen-Activated Protein Kinases and NF-κB Are Involved in TNF-α Responses to Group B Streptococci1 , 2002, The Journal of Immunology.

[44]  R. Doerge,et al.  Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. , 1999, Journal of immunology.

[45]  S. Akira,et al.  Toll-like receptors; their physiological role and signal transduction system. , 2001, International immunopharmacology.

[46]  Jeonghee Cho,et al.  Induction of COX‐2 by LPS in macrophages is regulated by Tpl2‐dependent CREB activation signals , 2002, The EMBO journal.

[47]  J. Kuratsu,et al.  Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants , 1989, The Journal of experimental medicine.

[48]  Hiroyuki Yamada,et al.  Interferon Regulatory Factor 1 in Mycobacterial Infection , 2002, Microbiology and immunology.

[49]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[50]  M. Wills-Karp,et al.  Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness. , 2002, American journal of respiratory cell and molecular biology.

[51]  P. Rutgeerts,et al.  Antiadhesion molecule therapy in inflammatory bowel disease. , 2002, Inflammatory bowel diseases.

[52]  Mark Boothby,et al.  TCR-Independent CD30 Signaling Selectively Induces IL-13 Production Via a TNF Receptor-Associated Factor/p38 Mitogen-Activated Protein Kinase-Dependent Mechanism1 , 2002, The Journal of Immunology.

[53]  L. Rakić,et al.  Enhanced serum response element binding activity correlates with down-regulation of c-fos mRNA expression in the rat brain following repeated cortical lesions. , 1997, Brain research. Molecular brain research.

[54]  M. Tremblay,et al.  Mycobacterium tuberculosis mannose-capped lipoarabinomannan can induce NF-kappaB-dependent activation of human immunodeficiency virus type 1 long terminal repeat in T cells. , 1998, The Journal of general virology.

[55]  G. Chrousos,et al.  Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.

[56]  C. Weber.  Involvement of tyrosine phosphorylation in endothelial adhesion molecule induction , 1996, Immunologic research.

[57]  Y. Asano,et al.  Identification of IFN Regulatory Factor-1 Binding Site in IL-12 p40 Gene Promoter1 , 2003, The Journal of Immunology.

[58]  H. Okamura,et al.  Roles of Interleukin-18 in Tissue Destruction and Compensatory Reactions , 2002, Journal of immunotherapy.

[59]  Michael G. Shields.  Translator's Introduction , 2001 .

[60]  Scott M. Seo,et al.  Granulocyte colony-stimulating factor promotes adhesion of neutrophils. , 2003, American journal of physiology. Cell physiology.

[61]  P. Pandolfi,et al.  Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms , 2002, The Journal of cell biology.

[62]  S. Ruben,et al.  I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity. , 1992, Genes & development.

[63]  M. Yamazaki,et al.  Tumor necrosis factor α (TNF-α)-induced prostaglanding E2 release is mediated by the activation of cyclooxygenase-2 (COX-2)transcription via NFκB in human gingival fibroblasts , 2002, Molecular and Cellular Biochemistry.

[64]  J. Leiro,et al.  In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes. , 2003, Biochemical pharmacology.

[65]  H. Schellekens,et al.  Cytokines and the immune response , 1996, Biotherapy.

[66]  G. Suzuki,et al.  An alternate pathway for type 1 T cell differentiation. , 1999, International immunology.

[67]  P. Baeuerle.  The inducible transcription activator NF-κB: regulation by distinct protein subunits , 1991 .

[68]  R. Andriantsitohaina,et al.  Wine polyphenols modulate calcium handling in rat aorta: involvement of nitric oxide pathway , 2002, Fundamental & clinical pharmacology.

[69]  G. Ghosh,et al.  Regulation of DNA binding by Rel/NF-κB transcription factors: structural views , 1999, Oncogene.

[70]  D. Novick,et al.  The promoter of IL-18 binding protein: Activation by an IFN-γ-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein β , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  K. Matsushima,et al.  Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line , 2022 .

[72]  Tieli Wang,et al.  The role of NF-κB in the regulation of cell stress responses , 2002 .

[73]  P. Scott.  IL-12: initiation cytokine for cell-mediated immunity. , 1993, Science.

[74]  H. Inoko,et al.  A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. , 2001, Genomics.

[75]  D. Adam,et al.  Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor , 1998, Journal of leukocyte biology.

[76]  A. Thorburn,et al.  An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells , 2001, Cell Death and Differentiation.

[77]  H. Abken,et al.  Interleukin-12 Antagonists as New Therapeutic Agents in Inflammatory Bowel Disease , 2003, Pathobiology.

[78]  G. Trinchieri.  Interleukin-12: a cytokine at the interface of inflammation and immunity. , 1998, Advances in immunology.

[79]  J. Leiro,et al.  Effect of (-)-epigallocatechin-3-gallate on respiratory burst of rat macrophages. , 2002, International immunopharmacology.

[80]  A. Mantovani,et al.  Toll-like receptor family and signalling pathway. , 2000, Biochemical Society transactions.

[81]  M. Palanki,et al.  Inhibitors of AP-1 and NF-kappa B mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity. , 2002, Current medicinal chemistry.

[82]  M. Magnani,et al.  The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). , 2000, Current drug targets.

[83]  Mira Jung,et al.  A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB , 1998, Oncogene.

[84]  F. Thaiss,et al.  Differential Activation of NF-κB, AP-1, and C/EBP in Endotoxin-Tolerant Rats: Mechanisms for In Vivo Regulation of Glomerular RANTES/CCL5 Expression1 , 2003, The Journal of Immunology.

[85]  S. Ghosh,et al.  Signal transduction through NF-κB , 1998 .

[86]  Munro Jm.  Endothelial-leukocyte adhesive interactions in inflammatory diseases. , 1993 .

[87]  J. Hamilton,et al.  Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor. , 1990, Blood.

[88]  S. Spiegel,et al.  The potent lipid mitogen sphingosylphosphocholine activates the DNA binding activity of upstream stimulating factor (USF), a basic helix-loop-helix-zipper protein. , 1998, Biochimica et biophysica acta.

[89]  S. Hanazawa,et al.  TGF‐β inhibits lipopolysaccharide‐stimulated activity of c‐Jun N‐terminal kinase in mouse macrophages , 1999, FEBS letters.

[90]  B. Rollins,et al.  Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.

[91]  F. Ubeira,et al.  Modulation of rat macrophage function by the Mangifera indica L. extracts Vimang and mangiferin. , 2002, International immunopharmacology.

[92]  K. Decker,et al.  The response of liver macrophages to inflammatory stimulation. , 1998, The Keio journal of medicine.

[93]  J. Cavaillon,et al.  Pro- versus anti-inflammatory cytokines: myth or reality. , 2001, Cellular and molecular biology.

[94]  J. Pestka,et al.  Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[95]  G. Stark,et al.  IRAK and TAK1 are required for IL‐18‐mediated signaling , 2001, European journal of immunology.

[96]  W. Liles,et al.  Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. , 2002, The Journal of infectious diseases.

[97]  Jen-kun Lin,et al.  (−)-Epigallocatechin-3-gallate Blocks the Induction of Nitric Oxide Synthase by Down-Regulating Lipopolysaccharide-Induced Activity of Transcription Factor Nuclear Factor-κB , 1997 .

[98]  Michael T. Wilson,et al.  Cytokine-inducing components of periodontopathogenic bacteria. , 1996, Journal of periodontal research.

[99]  T. Grundström,et al.  Regulation of c-Rel Nuclear Localization by Binding of Ca2+/Calmodulin , 2003, Molecular and Cellular Biology.

[100]  Y. Nomura.  NF-κB activation and IκBα dynamism involved in iNOS and chemokine induction in astroglial cells , 2001 .

[101]  A. Leonardi,et al.  Association of the Adaptor TANK with the IκB Kinase (IKK) Regulator NEMO Connects IKK Complexes with IKKε and TBK1 Kinases* , 2002, The Journal of Biological Chemistry.

[102]  E. Morii,et al.  Interaction and Cooperation of mi Transcription Factor (MITF) and Myc-associated Zinc-finger Protein-related Factor (MAZR) for Transcription of Mouse Mast Cell Protease 6 Gene* , 2002, The Journal of Biological Chemistry.

[103]  H. Wagner,et al.  Bacterial CpG-DNA licenses TLR9. , 2002, Current topics in microbiology and immunology.

[104]  Wei Zhang,et al.  Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-γ induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression , 2003, Oncogene.

[105]  T. Taniguchi,et al.  Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. , 1997, Immunity.

[106]  B. Rayet,et al.  Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.